Unit
- Definition: Restless Legs Syndrome is a sensorimotor disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations. Symptoms worsen during rest or inactivity, improve with movement, and follow a circadian pattern with peak severity in the evening or night.
- Historical recognition: First described in 1672 by Sir Thomas Willis, RLS was later systematically characterized by Karl-Axel Ekbom in the 1940s, leading to the alternative name Ekbom syndrome. Early descriptions noted the odd sensations and relief with movement.
- Nomenclature evolution: Over time, the terminology shifted from restless legs to acknowledge broader features. The International Restless Legs Syndrome Study Group (IRLSSG) was formed in 1995 to standardize diagnostic criteria and promote research.
- Prevalence estimates: Population studies show RLS affects 5-10% of adults in Western countries, with higher rates in women and increasing prevalence with age. About 2-3% have clinically significant symptoms requiring treatment.
- Underdiagnosis issue: Many patients do not report symptoms or are misdiagnosed as having peripheral neuropathy, venous insufficiency, or psychiatric conditions. Average time from symptom onset to diagnosis is several years.
- Impact on sleep: The circadian worsening of RLS leads to difficulty initiating sleep, frequent awakenings, and non-restorative sleep. This contributes to daytime fatigue, cognitive dysfunction, and reduced productivity.
- Quality of life burden: Chronic RLS is associated with depression, anxiety, and impaired social functioning, comparable to other chronic conditions like diabetes and osteoarthritis.
- Healthcare utilization: Patients with undiagnosed RLS often undergo unnecessary tests and treatments. Proper education can streamline care and reduce healthcare system burden.
- Pathophysiology: RLS is linked to dysfunction in dopamine pathways and iron metabolism in the brain. Reduced iron stores impair dopamine synthesis and receptor function, leading to abnormal sensorimotor integration. Imaging studies show reduced striatal dopamine D2 receptor binding, supporting this central mechanism.
- Genetic factors: Family studies indicate a strong hereditary component, with up to 60% of idiopathic cases having a positive family history. Genome-wide association studies have identified several risk variants, including those affecting BTBD9 and MEIS1 genes, which influence iron regulation and circadian rhythms.
- Secondary causes: Secondary RLS can arise from iron deficiency anemia, end-stage renal disease, pregnancy, or use of certain medications such as antidepressants and antihistamines. Identifying and addressing these underlying causes often leads to symptom improvement or resolution.
- Diagnostic criteria: The IRLSSG established five essential criteria: urge to move legs, worsening at rest, relief with movement, worsening in evening or night, and exclusion of other mimics. Supportive features include family history, response to dopaminergic therapy, and presence of periodic limb movements during sleep.
Scope of Practice
Role: Primary Care Provider in Initial Assessment
Within scope:
- Screening for RLS symptoms using validated questions during routine visits
- Conducting a basic clinical history including medication review and iron status
- Identifying red flags that require specialist referral
- Providing general sleep hygiene and lifestyle advice
Outside scope:
- Interpreting advanced diagnostic tests like polysomnography
- Managing treatment-resistant cases requiring combination therapy
- Diagnosing complex differentials such as peripheral neuropathy
- Prescribing opioids for refractory RLS
Quick Revision
- RLS is a common sensorimotor disorder with circadian pattern and relief on movement.
- Historical descriptions date back centuries; modern criteria were established in 1995.
- Prevalence is 5-10% in adults, but diagnosis is often delayed due to underreporting.
- Primary care providers can screen and manage mild cases but should refer complex patients.